Your browser doesn't support javascript.
loading
Efficacy and safety of exogenous beta-hydroxybutyrate for preventive treatment in episodic migraine: A single-centred, randomised, placebo-controlled, double-blind crossover trial.
Putananickal, Niveditha; Gross, Elena C; Orsini, Anna-Lena; Schmidt, Simone; Hafner, Patricia; Gocheva, Vanya; Nagy, Sara; Henzi, Bettina C; Rubino, Daniela; Vogt, Deborah R; Cichon, Sven; Sandor, Peter; Fischer, Dirk.
Afiliación
  • Putananickal N; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Gross EC; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Orsini AL; Department of Neurology, University of Basel Hospital, University of Basel, Switzerland.
  • Schmidt S; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Hafner P; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Gocheva V; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Nagy S; Department of Neurology, University of Basel Hospital, University of Basel, Switzerland.
  • Henzi BC; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Rubino D; Division of Neuropaediatrics, University of Basel Children's Hospital, University of Basel, Switzerland.
  • Vogt DR; Department of Clinical research, Clinical Trial Unit, University of Basel Hospital, University of Basel, Switzerland.
  • Cichon S; Institute of Medical Genetics and Pathology, University of Basel Hospital, University of Basel, Switzerland.
  • Sandor P; Department of Biomedicine, University of Basel, Switzerland.
  • Fischer D; RehaClinic, Bad Zurzach, Switzerland.
Cephalalgia ; 42(4-5): 302-311, 2022 04.
Article en En | MEDLINE | ID: mdl-34541914

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Migrañosos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Cephalalgia Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastornos Migrañosos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Cephalalgia Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido